SP Jain Institute of Management and Research launches management programme for women

The programme is called the Management Programme for Women, an 11-month, full time, post graduate programme. Read more »

RBI asks banks to lay down clear policy on stressed asset sale

To further strengthen banks' ability to resolve their stressed assets effectively, RBI has come out with an "improved framework" governing sale of such assets. Read more »

Delhi may see 445 MW of power supply shortage

Power allocated to these DISCOMs from Aravali Power Company is 445 MW and the average monthly energy bill is around Rs 87 crore for the current fiscal. Read more »

Railways offers Rs 10 lakh insurance cover for train travel

A person booking a train ticket through the IRCTC website will be able to opt for travel insurance cover for a premium of 92 paise only. Read more »

Quality of engineers very sub-standard in India: E Sreedharan

Sreedharan referred to a study conducted by a magazine which surveyed some 300 engineering colleges to conclude that only 29 per cent engineers are employable. Read more »

CIL, ICFRE sign MoU for green issues in coal mining

The MoU will also help in improving the rehabilitation and reclamation of the mined out areas, and official statement said. Read more »

CESC starts power distribution in Rajasthan

“At Kota we will follow CESC’s customer-centric initiatives to provide best-in-class services to power consumers by developing and modernising the city’s distribution systems.” Read more »

21 lakh solar certificates remain unsold

Solar certificates were sold at Rs 3,500 per certificates while non-solar RECs were sold at Rs 1,500 per certificates – the respective floor prices. Read more »

Mukesh Ambani says RIL, BP will not drop cost recovery arbitration for KG-D6

Ambani refrained from commenting on the report by the panel headed by former chief justice of Delhi High court AP Shah detailed Tuesday. Read more »

Lupin arm gets tentative FDA nod for anti-bacterial drug

Gavis has received tentative approval for its Azithromycin for oral suspension USP from the USFDA, Lupin said in a BSE filing. Read more »